David R. Bauer
Lawyers
Filters
Hinge Health $503 million IPO
The shares are listed on the New York Stock Exchange
Qualcomm $1.5 billion notes offering
The investment-grade notes are due 2030, 2032 and 2035
Atara Biotherapeutics registered direct offering
The stock is listed on Nasdaq
Biogen $1.75 billion senior notes offering
The investment-grade notes are due 2031, 2035 and 2055
Insulet $450 million senior notes offering
The high-yield notes are due 2033
Nova Biomedical $2.2 billion acquisition by Advanced Instruments
We are advising Nova Biomedical on the transaction
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
Beam Therapeutics $500 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Endo divestiture of International Pharmaceuticals business
We are advising Endo on the transaction
Tenaya Therapeutics $52.5 million units offering
The units comprise common stock and warrants